Analysts Set The Cigna Group (NYSE:CI) Target Price at $394.64

Shares of The Cigna Group (NYSE:CI) have been assigned a consensus rating of “Buy” from the fifteen analysts that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $394.64.

CI has been the subject of a number of analyst reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $400.00 target price on shares of The Cigna Group in a research note on Wednesday, October 23rd. Stephens reiterated an “overweight” rating and set a $410.00 price objective on shares of The Cigna Group in a research note on Friday, November 1st. Royal Bank of Canada cut their target price on The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. StockNews.com lowered The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Finally, Jefferies Financial Group increased their price objective on shares of The Cigna Group from $402.00 to $422.00 and gave the company a “buy” rating in a research report on Tuesday, September 17th.

Institutional Trading of The Cigna Group

Large investors have recently added to or reduced their stakes in the business. Ulland Investment Advisors LLC increased its position in The Cigna Group by 2,500.0% in the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after buying an additional 100 shares in the last quarter. Prospera Private Wealth LLC bought a new stake in The Cigna Group during the 3rd quarter worth approximately $37,000. Harbor Capital Advisors Inc. purchased a new position in The Cigna Group during the third quarter valued at approximately $45,000. Private Ocean LLC boosted its position in shares of The Cigna Group by 29.9% in the second quarter. Private Ocean LLC now owns 200 shares of the health services provider’s stock worth $66,000 after purchasing an additional 46 shares during the period. Finally, Intact Investment Management Inc. bought a new stake in shares of The Cigna Group during the 3rd quarter valued at $69,000. 86.99% of the stock is currently owned by institutional investors.

The Cigna Group Stock Up 1.7 %

Shares of NYSE:CI opened at $281.63 on Thursday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.72 and a current ratio of 0.72. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83. The firm has a market capitalization of $78.34 billion, a P/E ratio of 26.57, a P/E/G ratio of 0.88 and a beta of 0.50. The stock has a 50 day moving average price of $319.28 and a 200-day moving average price of $334.56.

The Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 EPS for the quarter, beating the consensus estimate of $7.22 by $0.29. The business had revenue of $63.70 billion during the quarter, compared to analyst estimates of $59.58 billion. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The company’s revenue for the quarter was up 29.8% on a year-over-year basis. During the same quarter last year, the firm posted $6.77 earnings per share. As a group, equities research analysts anticipate that The Cigna Group will post 28.5 EPS for the current fiscal year.

The Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th were issued a $1.40 dividend. This represents a $5.60 dividend on an annualized basis and a yield of 1.99%. The ex-dividend date was Wednesday, December 4th. The Cigna Group’s dividend payout ratio is 52.83%.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.